Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 684  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 »   Next article
 »   Previous article
 »   Table of Contents

 Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded62    
    Comments [Add]    

Recommend this journal


Year : 2020  |  Volume : 68  |  Issue : 5  |  Page : 985--988

Acute and Chronic Anti-ganglioside Neuropathies: From Theory to Practice in Buenos Aires, Argentina

1 Department of Neurology, Intensive Care Unit and Internal Medicine, Alfredo Lanari Institute of Medical Research, Av. Combatientes de Malvinas 3150; Higher Studies Center of Human Sciences and Health (CAECHIS), Universidad Abierta Interamericana, CONICET. Av. San Juan 951, Buenos Aires, Argentina
2 Department of Neurology, Intensive Care Unit and Internal Medicine, Alfredo Lanari Institute of Medical Research, Av. Combatientes de Malvinas 3150, Buenos Aires, Argentina

Correspondence Address:
Dr. Cecilia Quarracino
Av. Combatientes de Malvinas 3150, Buenos Aires
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0028-3886.294547

Rights and Permissions

Background and Aims: During the last two decades important advances have been made regarding the knowledge of immunomediated neuropathies, which entitled them to evolve from a theoretical existence to subtype differentiation. Nevertheless, questions regarding antigen topography or antibody's pathogenicity still need to be answer. Moreover, antibody typification is not necessarily available during clinical practice and usually diagnostic decisions or follow-up are done without it. The aim of this study is to raise awareness of the importance of divergent clinical findings in patients with immunomediated neuropathies. Methods: We present an acute and a chronic case of anti-ganglioside neuropathy immunologically studied with the best anti-ganglioside antibody panel available nowadays in our country along with an update of the current knowledge of these entities. Results: Although there is no consensus regarding the pathogenicity of these antibodies, diverging clinical features (mainly ataxia and ophthalmoparesis) and disease prognosis (as markers of axonal damage) are known to be associated with different antibodies. Conclusions: Antibody characterization in anti-ganglioside neuropathies is an evolving field, which we believe should periodically updated and minded for patient's diagnosis and follow-up, even if laboratory confirmation is not immediate, if available at all.


Print this article     Email this article

Online since 20th March '04
Published by Wolters Kluwer - Medknow